SpaceX CEO Elon Musk appeared to confirm plans for a listing in December. The company could seek to raise $30 billion.
US initial public offerings delivered underwhelming results in 2025 as equity-market volatility and increasing scrutiny ...
Aktis Oncology Inc., a clinical-stage biotechnology company focused on using so-called radiopharmaceuticals for treatments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback